On December 20, 2022, Skylight Health Group Inc. closed the transaction. The company has amended the terms of the transaction. The company received CAD 2,233,876.48 in second and final tranche, issued 6,762,000 debentures at an issue price of CAD 1,000 per debenture for gross proceeds of CAD 6,762,004.48 ($4,928,000) in the transaction.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from one placee. The company paid CAD 477,575 as finder's fees to Northland Capital Markets.